Suven Life Sciences Ltd - Stock Price

  • NSE : SUVEN
  • BSE : 530239
  • ISIN CODE : INE495B01038
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Suven Life Sciences Ltd is not traded on BSE/NSE
NSE
280.30
-1.06 %-3
BSE
280.20
-1.08 %-3.05

Ratios

Parameter MAR 19  MAR 18  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)6.839.72-29.71
   CEPS(Rs)8.8511.66-24.13
   DPS(Rs)1.501.500.00
   Book NAV/Share(Rs)65.2960.298.29
   Tax Rate(%)45.2336.7423.11
Margin Ratios
   Core EBITDA Margin(%)24.7132.25-23.37
   EBIT Margin(%)24.4932.01-23.48
   Pre Tax Margin(%)23.9231.27-23.49
   PAT Margin (%)13.1019.78-33.76
   Cash Profit Margin (%)16.9823.74-28.50
Performance Ratios
   ROA(%)7.8612.84-38.79
   ROE(%)10.8817.25-36.92
   ROCE(%)19.4626.01-25.18
   Asset Turnover(x)0.600.65-7.60
   Sales/Fixed Asset(x)1.741.730.83
   Working Capital/Sales(x)1.401.400.25
Efficiency Ratios
   Fixed Capital/Sales(x)0.570.58-0.83
   Receivable days58.2231.3485.79
   Inventory Days81.5767.7120.47
   Payable days43.0438.7910.97
Valuation Parameters
   PER(x)38.1917.27121.19
   PCE(x)29.4814.39104.92
   Price/Book(x)4.002.7843.59
   Yield(%)0.570.89-35.68
   EV/Net Sales(x)5.043.4347.20
   EV/Core EBITDA(x)17.779.5286.67
   EV/EBIT(x)20.5810.7092.38
   EV/CE(x)2.812.0934.43
   M Cap / Sales5.003.4246.52
Growth Ratio
   Net Sales Growth(%)6.1215.04-59.32
   Core EBITDA Growth(%)-16.3249.78-132.79
   EBIT Growth(%)-18.8055.45-133.91
   PAT Growth(%)-29.7141.86-170.96
   EPS Growth(%)-29.7141.86-170.96
Financial Stability Ratios
   Total Debt/Equity(x)0.050.043.30
   Current Ratio(x)2.582.98-13.39
   Quick Ratio(x)2.062.37-12.96
   Interest Cover(x)43.0643.25-0.43
   Total Debt/Mcap(x)0.010.02-28.06

Latest News

close